An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN

Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: a clinicopathological study

(2017) Shree G Sharma et al.   MODERN PATHOLOGY

An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain–Containing 7A–Specific Antibodies in Membranous Nephropathy

(2016) Elion Hoxha et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

(2016) Karine Dahan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

MP272PLA2R ANTIBODIES AND PLA2R AND THSD7A GLOMERULAR DEPOSITS IN PSORIASIS PATIENTS WITH MEMBRANOUS NEPHROPATHY

(2016) Yongchun Ge et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

A Mechanism for Cancer-Associated Membranous Nephropathy

(2016) Elion Hoxha et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy

(2015) Takamasa Iwakura et al.   PLoS One

Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy

(2014) Nicola M. Tomas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Soluble THSD7A Is an N-Glycoprotein That Promotes Endothelial Cell Migration and Tube Formation in Angiogenesis

(2011) Meng-Wei Kuo et al.   PLoS One

Membranous nephropathy: recent travels and new roads ahead

(2010) Laurence H. Beck et al.   KIDNEY INTERNATIONAL

M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy

(2009) Laurence H. Beck et al.   NEW ENGLAND JOURNAL OF MEDICINE